Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis

Osteoarthritis (OA) is a degenerative joint disease that causes pain and bone deterioration driven by an increase in prostaglandins (PGs) and inflammatory cytokines. Current treatments focus on inhibiting prostaglandin production, a pro-inflammatory lipid metabolite, with NSAID drugs; however, other...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Cindy B. McReynolds, Sung Hee Hwang, Jun Yang, Debin Wan, Karen Wagner, Christophe Morisseau, Dongyang Li, William K. Schmidt, Bruce D. Hammock
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019-05-01
Col·lecció:Frontiers in Pharmacology
Matèries:
soluble epoxide hydrolase
osteoarthritis
epoxyeicostrienoic acids
analgesic
non-opioid analgesic
non-NSAID analgesic
Accés en línia:https://www.frontiersin.org/article/10.3389/fphar.2019.00533/full
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars